Effects of Adalimumab-adbm Versus Adalimumab Reference Product on Patient-Reported Outcomes in Rheumatoid Arthritis: Results from VOLTAIRE-RA
Authors
- Vibeke Strand (ORCID: https://orcid.org/0000-0003-4978-4072)
- Dorothy McCabe (ORCID: https://orcid.org/0009-0007-9583-4671)
- Shaun Bender (ORCID: https://orcid.org/0000-0002-7589-4534)
Institutions
- Alnylam Pharmaceuticals (United States) (US)
- Portola Pharmaceuticals (United States) (US)
- Boehringer Ingelheim (United States) (US)
- Stanford University (US)
Publication Details
- Journal
- Rheumatology and Therapy
- Published
- 2024-08-09
- DOI
- https://doi.org/10.1007/s40744-024-00687-w
- Citations
- 1
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.47